MARISSA GUIDRY: Open Payments
NPI 1265864599 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 90 payments from 25 companies in 2025. Trend: 2023 $862 · 2024 $1,090 · 2025 $1,567
Food & beverage: $1,567
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $198 |
| Otsuka America Pharmaceutical, Inc. | 17 | $188 |
| Abbott Laboratories | 5 | $172 |
| Novo Nordisk Inc | 10 | $140 |
| AtriCure, Inc. | 1 | $113 |
| PFIZER INC. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Phathom Pharmaceuticals, Inc. | 9 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
Products named: REXULTI, FREESTYLE LIBRE 3, AtriCure cryoICE Cryoablation System (CRYO2), Ozempic, PREVNAR 20, MOUNJARO, LEQVIO, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
